Market Overview:
The purity level of 95% held the largest share in terms of volume in 2017 and is expected to maintain its dominance during the forecast period as well. This can be attributed to its low cost and easy availability compared with other purity levels. However, with technological advancements being made in this field, higher purity levels are expected to gain traction over time.
Product Definition:
It has been found to improve cognitive function and memory in animal models, and may have potential as a therapy for Alzheimer's disease.
Purity Above 95%:
It's a white crystalline solid that is soluble in water and ethanol. The product has an odor similar to butyl alcohol and is very hygroscopic with a tendency to form microcrystalline deposits that are insoluble in organic solvents.
Purity Above 97%:
It is a chemical that has been used in pharmaceuticals and nutraceuticals. Purity Above 97% can be easily manufactured by extraction of the lactone from chamomile tea, which gives it a distinct flavor and odor.
Application Insights:
The chemical synthesis segment held the largest share of over 30% in 2017. This can be attributed to the growing demand for chemicals with high stability such as 3-hydroxybutyrate and butyraldehyde from various industries such as pharmaceuticals, paints and coatings among others. Furthermore, increasing R&D investments by major companies are expected to boost product demand in near future.
Pharmaceutical industry was one of the fastest growing segments owing to extensive research activities at universities and institutes across the globe regarding drug discovery using HBAs as a model compound for brain chemistry modification has resulted in increased product consumption during clinical trials.
Regional Analysis:
The region is expected to continue its dominance over the forecast period as well due to presence of key manufacturers such as Wako Pure Chemical Ltd., Tianjin Tianjie Biochemical Co., Ltd., and Shanghai Xuyang Pharmaceutical Co., Ltd. in China along with other Southeast Asian countries.
The pharmaceutical industry is one of the significant sectors contributing towards economic growth.
Growth Factors:
- Increasing demand for 3-Hydroxybutyrolactone in various end-use industries such as pharmaceuticals, cosmetics, and food additives.
- Growing awareness about the benefits of 3-Hydroxybutyrolactone among consumers is expected to fuel its demand over the forecast period.
- Rising R&D investments by key players for the development of new applications of 3-Hydroxybutyrolactone is likely to propel market growth during the forecast period.
- Increasing use of 3-hydroxybutyrate in weight management supplements is projected to boost market growth over the next few years
Scope Of The Report
Report Attributes
Report Details
Report Title
3-Hydroxybutyrolactone Market Research Report
By Type
Purity Above 95%, Purity Above 97%, Purity Above 99%, Other
By Application
Catalyst, Pharmaceutical Industry
By Companies
AB Enterprises, Kalion, Kaneka Corporation, Shandong Zhouhe Chemical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
241
Number of Tables & Figures
169
Customization Available
Yes, the report can be customized as per your need.
Global 3-Hydroxybutyrolactone Market Report Segments:
The global 3-Hydroxybutyrolactone market is segmented on the basis of:
Types
Purity Above 95%, Purity Above 97%, Purity Above 99%, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Catalyst, Pharmaceutical Industry
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AB Enterprises
- Kalion
- Kaneka Corporation
- Shandong Zhouhe Chemical
Highlights of The 3-Hydroxybutyrolactone Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Purity Above 95%
- Purity Above 97%
- Purity Above 99%
- Other
- By Application:
- Catalyst
- Pharmaceutical Industry
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the 3-Hydroxybutyrolactone Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
3-Hydroxybutyrolactone is a ketone body produced by the liver when it breaks down fatty acids. It is also found in small amounts in some fruits and vegetables.
Some of the key players operating in the 3-hydroxybutyrolactone market are AB Enterprises, Kalion, Kaneka Corporation, Shandong Zhouhe Chemical.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. 3-Hydroxybutyrolactone Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. 3-Hydroxybutyrolactone Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. 3-Hydroxybutyrolactone Market - Supply Chain
4.5. Global 3-Hydroxybutyrolactone Market Forecast
4.5.1. 3-Hydroxybutyrolactone Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. 3-Hydroxybutyrolactone Market Size (000 Units) and Y-o-Y Growth
4.5.3. 3-Hydroxybutyrolactone Market Absolute $ Opportunity
5. Global 3-Hydroxybutyrolactone Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. 3-Hydroxybutyrolactone Market Size and Volume Forecast by Type
5.3.1. Purity Above 95%
5.3.2. Purity Above 97%
5.3.3. Purity Above 99%
5.3.4. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global 3-Hydroxybutyrolactone Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. 3-Hydroxybutyrolactone Market Size and Volume Forecast by Application
6.3.1. Catalyst
6.3.2. Pharmaceutical Industry
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global 3-Hydroxybutyrolactone Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. 3-Hydroxybutyrolactone Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global 3-Hydroxybutyrolactone Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. 3-Hydroxybutyrolactone Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global 3-Hydroxybutyrolactone Demand Share Forecast, 2019-2026
9. North America 3-Hydroxybutyrolactone Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America 3-Hydroxybutyrolactone Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America 3-Hydroxybutyrolactone Market Size and Volume Forecast by Application
9.4.1. Catalyst
9.4.2. Pharmaceutical Industry
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America 3-Hydroxybutyrolactone Market Size and Volume Forecast by Type
9.7.1. Purity Above 95%
9.7.2. Purity Above 97%
9.7.3. Purity Above 99%
9.7.4. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America 3-Hydroxybutyrolactone Demand Share Forecast, 2019-2026
10. Latin America 3-Hydroxybutyrolactone Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America 3-Hydroxybutyrolactone Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America 3-Hydroxybutyrolactone Market Size and Volume Forecast by Application
10.4.1. Catalyst
10.4.2. Pharmaceutical Industry
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America 3-Hydroxybutyrolactone Market Size and Volume Forecast by Type
10.7.1. Purity Above 95%
10.7.2. Purity Above 97%
10.7.3. Purity Above 99%
10.7.4. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America 3-Hydroxybutyrolactone Demand Share Forecast, 2019-2026
11. Europe 3-Hydroxybutyrolactone Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe 3-Hydroxybutyrolactone Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe 3-Hydroxybutyrolactone Market Size and Volume Forecast by Application
11.4.1. Catalyst
11.4.2. Pharmaceutical Industry
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe 3-Hydroxybutyrolactone Market Size and Volume Forecast by Type
11.7.1. Purity Above 95%
11.7.2. Purity Above 97%
11.7.3. Purity Above 99%
11.7.4. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe 3-Hydroxybutyrolactone Demand Share, 2019-2026
12. Asia Pacific 3-Hydroxybutyrolactone Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific 3-Hydroxybutyrolactone Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific 3-Hydroxybutyrolactone Market Size and Volume Forecast by Application
12.4.1. Catalyst
12.4.2. Pharmaceutical Industry
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific 3-Hydroxybutyrolactone Market Size and Volume Forecast by Type
12.7.1. Purity Above 95%
12.7.2. Purity Above 97%
12.7.3. Purity Above 99%
12.7.4. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific 3-Hydroxybutyrolactone Demand Share, 2019-2026
13. Middle East & Africa 3-Hydroxybutyrolactone Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa 3-Hydroxybutyrolactone Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa 3-Hydroxybutyrolactone Market Size and Volume Forecast by Application
13.4.1. Catalyst
13.4.2. Pharmaceutical Industry
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa 3-Hydroxybutyrolactone Market Size and Volume Forecast by Type
13.7.1. Purity Above 95%
13.7.2. Purity Above 97%
13.7.3. Purity Above 99%
13.7.4. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa 3-Hydroxybutyrolactone Demand Share, 2019-2026
14. Competition Landscape
14.1. Global 3-Hydroxybutyrolactone Market: Market Share Analysis
14.2. 3-Hydroxybutyrolactone Distributors and Customers
14.3. 3-Hydroxybutyrolactone Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. AB Enterprises
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Kalion
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Kaneka Corporation
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Shandong Zhouhe Chemical
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. COMPANY5
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
